Don’t Use Topiramate In Pregnancy Unless No Other Drug Is Available, Says EU Drug Safety Committee
Executive Summary
The European Medicines Agency’s pharmacovigilance committee said its safety review of topiramate took account of available data including three recent observational studies.
You may also be interested in...
EMA Probe Into Paternal Valproate Exposure Risk Continues After ‘Errors’ Found In Study
Initial results from a study indicate that children born to men taking valproate medicines are at an increased risk of having neurodevelopmental disorders, but “important limitations” and “errors” with the data highlight the need for further analysis.
Use of Gynecological Drugs Restricted In EU; ‘Urgent’ Safety Review Starts For Pholcodine
The European Medicines Agency has completed its investigation into the safety of nomegestrol and chlormadinone, and has started reviewing risks linked to the cough suppressant, pholcodine, and the epilepsy and migraine drug, topiramate.
EU Could Soon Have Three XBB.1.5 COVID-19 Vaccines For Winter Season
The head of the European Medicines Agency says a group of international regulators got together to ensure “global alignment” on the approach to be taken on COVID-19 vaccination.